Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adenosine 2A Receptor Antagonists for the Treatment of Motor Symptoms in Parkinson's Disease

Published:2015-07-25 Issue:4 Volume:2 Page:331-340
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Mov Disord Clin Pract

Author:

Pourcher Emmanuelle¹²,Huot Philippe³⁴

Affiliation:

1. Clinique Sainte-Anne Mémoire et Mouvement; Faculty of Medicine; Laval University; Quebec City Quebec Canada

2. Centre Thématique de Recherche en Neuroscience; Laval University; Quebec City Quebec Canada

3. Department of Pharmacology; Faculty of Medicine; University of Montreal; Montreal Quebec Canada

4. Division of Neurology; Centre Hospitalier de l'Université de Montréal; Montreal Quebec Canada

Funder

Parkinson Society Canada and Department of Pharmacology and Faculty of Medicine of University of Montreal

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mdc3.12187/fullpdf

Reference95 articles.

1. Pharmacological treatment of Parkinson disease: a review;Connolly;JAMA,2014

2. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD;Katzenschlager;Neurology,2008

3. Sydney multicenter study of Parkinson's disease: non-l-dopa-responsive problems dominate at 15 years;Hely;Mov Disord,2005

4. Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients. Parkinson Study Group;ParkinsonStudyGroup;Ann Neurol,1997

5. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study;ParkinsonStudyGroup;Arch Neurol,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Purinergic signaling: A gatekeeper of blood-brain barrier permeation;Frontiers in Pharmacology;2023-02-07

2. Adenosine A2A antagonists and Parkinson’s disease;International Review of Neurobiology;2023

3. A_2A Adenosine Receptor Antagonists and their Potential in Neurological Disorders;Current Medicinal Chemistry;2022-08

4. Pathophysiological Role and Medicinal Chemistry of A2A Adenosine Receptor Antagonists in Alzheimer’s Disease;Molecules;2022-04-21

5. Adenosine A2AR/A1R Antagonists Enabling Additional H3R Antagonism for the Treatment of Parkinson’s Disease;Journal of Medicinal Chemistry;2021-06-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3